Defined Benefit
Defined Contribution
Insurance Assets
Nonprofit

The Supermicro Conundrum: When Successful Small Cap Stocks Hurt Managers

The Supermicro Conundrum: When Successful Small Cap Stocks Hurt Managers
clock
4 min 3 sec

Only 50% of U.S. small cap growth managers outperformed the Russell 2000 Growth benchmark at the end of 1Q24. In comparison, 67% of small core managers and north of 75% of small value managers outperformed their comparable benchmarks. The dispersion in active management results between active small cap growth managers and their core and value counterparts can be strongly attributed to two culprits: Supermicro and Microstrategy.

Supermicro makes artificial intelligence (AI) infrastructure solutions; the stock’s fast and furious rise has been correlated with the increasing demand for AI, and to some degree with the continued dominance of Nvidia, one of the company’s most meaningful AI-related partnerships.

Microstrategy, on the other hand, is considered a bitcoin proxy; it is the largest corporate bitcoin holder, thus participating in the surge of cryptocurrency performance in 2023.

Big Surge for Supermicro and Microstrategy

By the end of 2023, Supermicro stock was up over 250% while Microstrategy stock was up over 330%; the stocks’ strong performance has extended thus far into 2024. Due to their combined position sizes in the Russell 2000 Growth and Russell 2000 Indices (6% and 4%, respectively), the returns of both stocks have been incredibly impactful to benchmark performance. For instance, as of March 2024, Supermicro alone contributed over 300 basis points to the Russell 2000 Growth’s total return of 7.6%. The concentration, both from a holdings and performance standpoint, is something we do not often see in the small cap benchmarks.

supermicro

Because of the position sizes and performance of Supermicro and Microstrategy, some managers with zero or underweight positions in these stocks have experienced some challenges with portfolio performance. Reasons cited by managers for zero or underweight exposures include:

  • Implementation hurdles: The market capitalization for Supermicro has increased substantially in a short period of time. Prior to the 2023 Russell reconstitution, Supermicro’s market cap hovered around $5 billion, which is also the average market cap for a Russell 2000 company. Between April and June 2023, its market cap increased to $13 billion (and ended the year at $15 billion). YTD 2024, its market cap has jumped to $60 billion. The stock even earned a place in the S&P 500 Index in March 2024 (concurrent with its position within the small cap benchmarks). For small cap managers with buy-and-sell disciplines which prescribe that transactions take place within the small cap range (under $1 billion to $10 billion), the purchase of or incremental adds to Supermicro after the 2023 reconstitution would have violated these construction guidelines. Similarly, many that owned the stock were forced to sell the position entirely once it graduated beyond the small cap market cap range.
  • Valuation: The precipitous rise in the stock prices for both companies led many managers to question the stocks’ respective risk/rewards and potential negative implications of participating at that stage in their life cycles.
  • Fundamentals: Some long-only active managers remain mixed on bitcoin-related/cryptocurrency investments, given their speculative nature. As for Supermicro, some managers have expressed broad concerns, ranging from management quality to the persistence of growth beyond the ongoing AI hardware cycle.

Thankfully, for active small cap growth (and core) managers, Supermicro and Microstrategy have graduated out of small cap benchmarks with the 2024 Russell reconstitution. While their exits may alleviate the pressure that managers have experienced in navigating their positions, these stocks have been a good impetus for managers to re-engage on their approach to risk management, particularly when there are stocks that comprise a significant portion of the total portfolio’s risk budget. Given that, as we head into the second half of 2024, there are important considerations for institutional investors to assess as they continue to engage with their small cap managers:

  • AI exposure and diversification of risk: Generally speaking, managers with exposure to the AI ecosystem, ranging from semiconductors to various AI-related themes within the Industrials sector (such as electrification and data centers) were able to mitigate some of the attribution challenges caused by underweight or zero exposure to Supermicro and Microstrategy combined. This suggests that AI is an important consideration from a portfolio construction and risk standpoint. If a manager’s view reflects a conservative view of AI and its value proposition going forward, it is worth asking how it will manage the active bet/risk of a contrary view should AI performance persist. Conversely, if a manager has a heavy active weight to AI as a theme, it also worth asking how holdings diversification, both within AI exposures and at the aggregate portfolio level, is maintained to ensure proper risk diversification within the portfolio.
  • Performance: While Supermicro and Microstrategy have graduated out of the small cap benchmarks, there will inevitably be a performance overhang, especially for portfolios that lacked exposure to these names and AI in general. Akin to the suggested dialogue on AI exposure, discussions on portfolio positioning and how it will iterate over time may be useful, particularly if today’s AI-heavy market backdrop persists.

Disclosures

The Callan Institute (the “Institute”) is, and will be, the sole owner and copyright holder of all material prepared or developed by the Institute. No party has the right to reproduce, revise, resell, disseminate externally, disseminate to any affiliate firms, or post on internal websites any part of any material prepared or developed by the Institute, without the Institute’s permission. Institute clients only have the right to utilize such material internally in their business.

Posted by

Share
Share on facebook
Share on twitter
Share on linkedin
Related Posts
Public Markets

Gains for Stocks Mask Wide Disparities; Little to No Change for Bonds

Kristin Bradbury
Callan expert analyzes the global stock and bond markets in 2Q24.
Operations

A Deeper Look at How We Did With Our Capital Markets Assumptions

Julia Moriarty
An analysis of how Callan's Capital Markets Assumptions performed over time by asset class.
Public Markets

Is This a Time for Active Managers to Shine?

Tony Lissuzzo
A post from a member of the Callan Nonprofit Group on how dispersion affects active management.
Public Markets

Stocks Continue Rally; Bond Returns Fall Amid Rate Cut Uncertainty

Kristin Bradbury
Callan expert analyzes the performance of global markets in 1Q24 and the outlook for the year.
Public Markets

The Magnificent Seven and Large Cap Portfolios: What Institutional Investors Need to Know

Nicole Wubbena
What institutional investors need to know about the Magnificent Seven and large cap stock portfolios
Public Markets

Stocks Near a Record High, and Bonds Reverse Course

Kristin Bradbury
Kristin Bradbury analyzes global stock and bond markets in 4Q23.
Public Markets

Tough Quarter for Stocks, with Bonds Facing Third Straight Annual Fall

Kristin Bradbury
Kristin Bradbury assesses the global markets in 3Q23.
Public Markets

An Investor's Guide to the Nasdaq-100's Special Rebalance

Mark Wood
Mark Wood analyzes the special rebalance implemented by the Nasdaq-100.
Public Markets

Tech Stocks Lead U.S. Indices Higher; Rate Increases Send Bonds Lower

Kristin Bradbury
Kristin Bradbury assesses the global stock and bond markets in 2Q23.
Public Markets

Gains for Stocks and Bonds but the Ride Was Bumpy

Kristin Bradbury
Kristin Bradbury writes about the rebound in 1Q23 for global stocks and bonds.

Callan Family Office

You are now leaving Callan LLC’s website and going to Callan Family Office’s website. Callan Family Office is not affiliated with Callan LLC.  Callan LLC has licensed the Callan® trademark to Callan Family Office for use in providing investment advisory services to ultra-high net worth clients, family foundations, and endowments. Callan Family Office and Callan LLC are independent, unaffiliated investment advisory firms separately registered with the Securities and Exchange Commission under the Investment Advisers Act of 1940.

Callan LLC is not responsible for the services and content on Callan Family Office’s website. Inclusion of this link does not constitute or imply an endorsement, sponsorship, or recommendation by Callan LLC of their website, or its contents, and Callan LLC is not responsible or liable for your use of it. When visiting their website, you are subject to Callan Family Office’s terms of use and privacy policies.